A genetic medicine company developing scalable, one-time curative in-vivo gene editing therapies based on a mutation-agnostic editing technology.
Create a free EquityFlow account to see Immitra Bio's 1 funding round, 8 investors, 12 similar companies.
Sign up free → Sign in